FDA rebukes 17 firms for selling fake Alzheimer’s drugs

FILE PHOTO: FDA Commissioner Scott Gottlieb speaks during an interview with Reuters in New York City, U.S., November 26, 2018. REUTERS/Brendan McDermid/File Photo

(Reuters) – The U.S. Food and Drug Administration (FDA) has warned more than a dozen companies against selling unapproved products which claim to treat Alzheimer’s disease and other serious ailments, the agency said on Monday. Many of these drugs, marketed as dietary supplements and sold online, have not been reviewed by the FDA and their […]

Continue reading this article with a Fiji Times online membership.

More Stories